VIPAZUR
LIVE

Serial Number

79446681

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 28, 2026

Add to watchlist:

No watchlists yet
View on USPTO

VIPAZUR Trademark

Serial Number: 79446681

VIPAZUR is a trademark filed by Novartis AG on January 28, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

January 28, 2026

Registration Date

Not Registered

Published for Opposition

May 19, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2026 PUBO
NOTIFICATION PROCESSED BY IB
May 14, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 13, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 29, 2026 OP2R
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 23, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 23, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 23, 2026 COAR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2026 CNSA
ASSIGNED TO EXAMINER
Apr 14, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 1, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 27, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 26, 2026 REPR